Descrição

Proton therapy, also called proton beam therapy, is a type of radiation therapy. Instead of using x-rays like regular radiation treatment, it uses protons to sends beams of high energy that can target tumors more precisely than X-ray radiation. The global proton therapy market is set to increase by US$ 1,029.8 milhões de 2022 para 2028, representing a compound annual growth rate (CAGR) de 13.1% durante o período de previsão.

O relatório fornece dados atualizados sobre o tamanho do mercado para o período 2018-2021 e previsão para 2028 covering key market aspects like sales value for proton therapy. The global proton therapy market is segmented on the basis of component, system type, aplicativo, usuário final, and region. On the basis of component, the global proton therapy market has been segmented into accelerators, beam delivery systems, services, software. The beam delivery systems segment is estimated to account for the largest share of the global proton therapy market. By system type, the global proton therapy market has been segmented into single room systems, multi room systems. The multi room systems segment held the largest revenue share in 2021. Based on application, the global proton therapy market is categorized into breast cancer, lung cancer, pediatric cancer, prostate cancer, skull base cancer, outros. Globally, the pediatric cancer segment made up the largest share of the proton therapy market. On the basis of end user, the global proton therapy market has been segmented into proton therapy centers, hospitais, outros. In terms of geography, the global proton therapy market has been segmented into Asia Pacific, Europa, América do Norte, Rest of the World (RoW).

The global proton therapy market is highly competitive. Some of the leading companies operating in the market are Hitachi Ltd., IBA (Ion Beam Applications SA), Koninklijke Philips N.V., Mevion Medical Systems Inc., RaySearch Laboratories AB, Sumitomo Heavy Industries Ltd (SHI), Varian Medical Systems Inc.

O relatório é um recurso inestimável para empresas e organizações ativas neste setor. It provides a cohesive picture of the proton therapy market to help drive informed decision making for industry executives, decisores políticos, acadêmico, e analistas.

Escopo do relatório

Component: accelerators, beam delivery systems, services, software
System type: single room systems, multi room systems
Aplicativo: breast cancer, lung cancer, pediatric cancer, prostate cancer, skull base cancer, outros
Usuário final: proton therapy centers, hospitais, outros
Região: Ásia-Pacífico, Europa, América do Norte, Rest of the World (RoW)
Anos considerados: este relatório cobre o período 2018 para 2028

Principais benefícios para as partes interessadas

– Get a comprehensive picture of the global proton therapy market
– Identifique setores de crescimento e tendências para investimento

Índice

Papel 1. Introdução
– Escopo do estudo
– Período de estudos
– Escopo geográfico
– Metodologia de Pesquisa
Papel 2. Proton therapy market overview
Papel 3. Market breakdown by component
– Accelerators
– Beam delivery systems
– Serviços
– Software
Papel 4. Market breakdown by system type
– Single room systems
– Multi room systems
Papel 5. Market breakdown by application
– Breast cancer
– Lung cancer
– Pediatric cancer
– Prostate cancer
– Skull base cancer
– Outros
Papel 6. Detalhamento do mercado por usuário final
– Proton therapy centers
– Hospitais
– Outros
Papel 7. Market breakdown by region
– Ásia-Pacífico
– Europa
– América do Norte
– Rest of the World (RoW)
Papel 8. Principais empresas
– Hitachi, Ltda.
– IBA (Ion Beam Applications SA)
– Koninklijke Philips N.V..
– Mevion Medical Systems, Inc..
– RaySearch Laboratories AB
– Sumitomo Heavy Industries, Ltda (SHI)
– Varian Medical Systems, Inc..
Sobre StrategyHelix
Isenção de responsabilidade